News and Trends 3 Dec 2018
First-in-Class Cancer Drug Gets €50M Boost
The biopharmaceutical company Aprea Therapeutics has raised €50M to fund a Phase III trial of its first-in-class cancer drug candidate, which kills tumor cells by restoring the function of a…